Female genital neoplasms

PubMed Free Full Text

Cervical cancer: vaccine

Africa, Asia

• Asian Pacific Journal of Cancer Prevention
  • Racial Disparities Associated with the Prevalence of Vaccine and Non-Vaccine HPV Types and Multiple HPV Infections between Asia and Africa: A Systematic Review and Meta-Analysis [2021]

Americas

• Centers for Disease Control and Prevention
  • Progress Toward Implementation of Human Papillomavirus Vaccination --- the Americas, 2006--2010 [2011]

• Pan American Health Organization
  • Methodology to calculate HPV Vaccine Coverage in the Region of the Americas [2019]
  • Human Papillomavirus (HPV) Vaccine

Australia

• Australian Family Physician
  • Abnormal Pap tests after the HPV vaccine [2009]

• Australian Institute of Health and Welfare
  • HPV immunisation rates 2015–16 [2018]

• Australian Journal of General Practice
  • Human papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule [2018]

• Department of Health and Aged Care
  • Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia [2020]
  • Human papillomavirus (HPV) | The Australian Immunisation Handbook [2018]

• EuroSurveillance
  • The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? [2018]

• Lancet Public Health
  • Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis [2016]

• PLoS ONE
  • Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia [2018]

Australia, New Zealand

• Royal Australian and New Zealand College of Obstetricians and Gynaecologists
  • Guidelines for HPV vaccine [2019]

Austria

• BMC Infectious Diseases
  • Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria [2016]

Botswana

• Centers for Disease Control and Prevention
  • Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project — Botswana, 2013 [2015]

Brazil

• Revista Latino-Americana de Enfermagem
  • Vaccination against human papillomavirus in Brazilian schoolchildren: National Survey of School Health, 2019 [2022]

• Revista Panamericana de Salud Pública
  • Paving pathways: Brazil's implementation of a national human papillomavirus immunization campaign [2015]

Canada

• BMC Infectious Diseases
  • Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis [2011]

• Canadian Family Physician
  • Effect of human papillomavirus vaccination on sexual behaviour among young females [2018]
  • Update on the new 9-valent vaccine for human papillomavirus prevention [2016]
  • HPV vaccine for cancer and wart prevention [2015]

• Canadian Paediatric Society
  • Human papillomavirus vaccine for children and adolescents [2018]

• Government of Canada
  • Human Papillomavirus Vaccine

• Human Vaccines & Immunotherapeutics
  • Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review [2023]

• Public Health Agency of Canada
  • Updated Recommendations on Human Papillomavirus Vaccines: 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule [2016]
  • Update On Human Papillomavirus (HPV) Vaccines [2012]

Caribbean

• Pan American Health Organization
  • HPV Vaccination: Toward the Elimination of Cervical Cancer in the Caribbean Countries. Virtual Meeting Report, 22–23 and 29–30 October 2020 [2021]

Chile

• BMC Public Health
  • Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model [2014]

China

• BMC Health Services Research
  • Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey [2022]

• BMC Infectious Diseases
  • Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China [2017]

• BMC Public Health
  • Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model [2022]
  • Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies [2016]

• European Journal of Cancer Care
  • Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature [2022]

• Frontiers in Public Health
  • Frequency of health care provider recommendations for HPV vaccination: a survey in three large cities in China [2023]
  • A national cross-sectional study on the influencing factors of low HPV vaccination coverage in mainland China [2023]

• Human Vaccines & Immunotherapeutics
  • Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women [2021]

• International Journal of Environmental Research and Public Health
  • HPV Vaccination Intentions of Female Students in Chinese Universities: A Systematic Literature Review and Meta-Analysis [2022]

• Preventive Medicine
  • A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in China [2021]

Costa Rica

• Journal of the National Cancer Institute
  • Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial [2023]

• Lancet Oncology
  • Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial [2022]

Cyprus

• BMC Women's Health
  • An analysis of the knowledge of adults aged between 18 and 45 on HPV along with their attitudes and beliefs about HPV vaccine: the Cyprus case [2023]

Denmark

• Acta Obstetricia et Gynecologica Scandinavica
  • High-grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study [2020]

• International Journal of Cancer
  • Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi-cohort vaccination against human papillomavirus infection [2023]
  • Prevalence of high-risk human papillomavirus after HPV-vaccination in Denmark [2020]

Developing countries

• Infectious Diseases in Obstetrics and Gynecology
  • Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries [2011]

Estonia

• BMC Infectious Diseases
  • The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia [2013]

Ethiopia

• BMC Public Health
  • Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis [2023]

• BMC Women's Health
  • Knowledge, attitude, and uptake of human papillomavirus vaccine among adolescent schoolgirls in Ethiopia: a systematic review and meta-analysis [2023]

• Frontiers in Public Health
  • A call for switching to a 1-dose 9vHPV national vaccination program in Ethiopia [2023]

Europe

• Cancer Medicine
  • HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level [2019]

• European Centre for Disease Prevention and Control
  • Efficacy, effectiveness and safety of HPV vaccination in women with conisation: a systematic review and meta-analyses [2024]
  • Human papillomavirus

• European Society of Gynaecological Oncology
  • Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy [2019]

• EuroSurveillance
  • Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma [2021]

• WHO European Region
  • Communicating with caregivers about the Human Papillomavirus vaccination: facilitator’s guide [2023]
  • Communicating with caregivers about the Human Papillomavirus vaccination: a tool to build confidence in communication skills among health workers [2023]

Fiji

• BMC Public Health
  • Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents [2015]

France

• EuroSurveillance
  • Can physicians and schools mitigate social inequalities in human papillomavirus vaccine awareness, uptake and vaccination intention among adolescents? A cross-sectional study, France, 2021 to 2022 [2023]

• Human Vaccines & Immunotherapeutics
  • Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history [2015]
  • A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France [2013]

Germany

• Frontiers in Public Health
  • Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study [2023]

Greece

• In Vivo
  • Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study [2020]

High-income countries

• BMC Public Health
  • Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis [2014]

• Expert Review of Vaccines
  • A review of data systems for assessing the impact of HPV vaccination in selected high-income countries [2023]

• Lancet
  • Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis [2019]

Hong Kong

• PLoS ONE
  • Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents [2018]

India

• Asian Pacific Journal of Cancer Prevention
  • HPV Vaccination of Girl Child in India: Intervention for Primary Prevention of Cervical Cancer [2018]

• ISRN Obstetrics and Gynecology
  • HPV Vaccination in India: Critical Appraisal [2014]

Indonesia

• PLoS ONE
  • Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis [2020]

International

• BMC Public Health
  • A systematic review of interventions to promote HPV vaccination globally [2023]

• International Federation of Gynecology and Obstetrics
  • FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV [2023]
  • Safety of HPV vaccination: a FIGO statement [2013]

• International Journal of STD & AIDS
  • A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries [2023]

• International Papillomavirus Society
  • IPVS statement on “Temporary HPV vaccine shortage: Implications globally to achieve equity” [2020]

• Lancet Public Health
  • Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis [2021]

• Preventive Medicine Reports
  • Cost and effectiveness of HPV vaccine delivery strategies: A systematic review [2022]

Iran

• Intervirology
  • Type-Specific Human Papillomavirus Prevalence in Iranian Women with Normal Cervical Cytology: The Impact of Current HPV Vaccines [2017]

Israel

• Journal of Lower Genital Tract Disease
  • Impact of COVID-19 Pandemic on Human Papillomavirus Vaccine Uptake in Israel [2023]

Japan

• Cancer Science
  • Disparities among Japanese municipalities in recommendations for routine and catch-up HPV vaccinations [2023]
  • A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan [2021]
  • Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program [2019]

• Human Vaccines & Immunotherapeutics
  • A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation [2023]
  • Changing trends in HPV vaccination in Japan [2022]
  • Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods [2021]

• Lancet Regional Health – Western Pacific
  • The looming health hazard: A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine [2021]
  • Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data [2021]

• Scientific Reports
  • Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine [2020]
  • Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year [2018]

• Vaccine
  • Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis [2022]

• Vaccines
  • Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program [2022]

Kenya

• EClinicalMedicine
  • Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence [2022]

Latin America and the Caribbean

• Pan American Health Organization
  • Evaluating the impact of the human papillomavirus vaccine in Latin America and the Caribbean [2023]

Lebanon

• BMC Pediatrics
  • Human papillomavirus vaccine knowledge and conspiracy beliefs among secondary school students in Lebanon [2023]

Low and middle income countries

• BMC Health Services Research
  • Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014 [2016]

• Human Vaccines & Immunotherapeutics
  • Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives [2022]

• JNCI Cancer Spectrum
  • Human Papillomavirus Vaccination After COVID-19 [2021]

• Jornal de Pediatria
  • HPV vaccination programs in LMIC: is it time to optimize schedules and recommendations? [2023]

• Public Health
  • Features of human papillomavirus vaccination education strategies in low- and middle-income countries: a scoping review [2022]

• Vaccine
  • Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review [2022]
  • Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects [2013]

Luxembourg

• Cancer Epidemiology
  • Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg [2019]

Malaysia

• BMC Public Health
  • Cost- effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia [2016]

• Frontiers in Public Health
  • The impact of the COVID-19 pandemic on the national HPV immunization program in Malaysia [2022]

Middle East, North Africa

• Eastern Mediterranean Health Journal
  • Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review [2018]

Morocco

• Pan African Medical Journal
  • Human papillomavirus vaccination in view of the National Cancer Control Plan 2020-2029 in Morocco [2023]

Netherlands

• International Journal of Cancer
  • Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer [2021]

New Zealand

• Ministry of Health New Zealand
  • Revitalising the National HPV Immunisation Programme [2015]
  • HPV Immunisation Programme Implementation Evaluation [2012]

Nigeria

• BMC Health Services Research
  • Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage [2017]

Norway

• BMC Public Health
  • Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway [2021]

• PLoS ONE
  • Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys [2014]

• Preventive Medicine
  • Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents [2015]

Peru

• PLoS ONE
  • Parental Acceptance of HPV Vaccine in Peru: A Decision Framework [2012]

Philippines

• BMC Public Health
  • A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines [2015]

• Cost Effectiveness and Resource Allocation
  • Incorporating economies of scale in the cost estimation in economic evaluation of PCV and HPV vaccination programmes in the Philippines: a game changer? [2018]

• Vaccine
  • The cost-effectiveness of human papillomavirus vaccination in the Philippines [2022]

Republic of Korea

• International Journal of Environmental Research and Public Health
  • Factors Associated with the HPV Vaccination among Korean Americans and Koreans: A Systematic Review [2021]

• Journal of Gynecologic Oncology
  • Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines [2021]
  • Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline [2019]
  • Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline [2016]

• Virology Journal
  • Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study [2021]

Saudi Arabia

• Frontiers in Oncology
  • HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and Vaccination [2014]

Senegal

• Vaccine
  • National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned [2022]
  • Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal [2022]

Singapore

• Society for Colposcopy and Cervical Pathology of Singapore
  • SCCPS Scientific Committee Position Paper on HPV Vaccination [2020]

South Africa

• BMC Infectious Diseases
  • Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence [2015]

• Clinical Drug Investigation
  • Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa [2022]

Spain

• EuroSurveillance
  • Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016 [2019]

• Human Vaccines & Immunotherapeutics
  • Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain [2022]

Sub-Saharan Africa

• BMC Public Health
  • Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review [2023]

• BMJ Open
  • Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis [2023]

• PLoS ONE
  • Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review [2014]

Sweden

• American Journal of Epidemiology
  • Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs [2021]

• Archives of Gynecology and Obstetrics
  • Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008–2018, and perspectives on cancer prevention [2021]

• British Journal of Cancer
  • Impact of HPV vaccination on cervical screening performance: a population-based cohort study [2020]

Switzerland

• BMC Infectious Diseases
  • Impact of HPV vaccination with Gardasil® in Switzerland [2017]

• BMC Public Health
  • Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland [2020]

• BMJ Open
  • Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study [2022]

Tanzania

• Health Policy and Planning
  • Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania [2016]

• Vaccine
  • Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019 [2022]
  • National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation [2022]
  • Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania's national HPV vaccine introduction [2022]

Thailand

• PLoS ONE
  • The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand [2021]

Togo

• Vaccine
  • Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo [2022]

Uganda

• Infectious Agents and Cancer
  • Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review [2011]

• Vaccine
  • Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country [2018]

United Kingdom

• BMC Infectious Diseases
  • Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK [2019]

• BMJ
  • Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study [2019]

• HSC Public Health Agency
  • Human papillomavirus (HPV) immunisation programme - Factsheet for healthcare professionals [2023]

• Human Vaccines & Immunotherapeutics
  • Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom [2015]

• PLoS ONE
  • HPV Serology Testing Confirms High HPV Immunisation Coverage in England [2016]

• Public Health Scotland
  • HPV immunisation statistics Scotland
  • HPV education pack

• UK Health Security Agency
  • Human papillomavirus (HPV): the green book, chapter 18a
  • HPV vaccination programme

• Vaccine
  • Risk of spontaneous abortion and other pregnancy outcomes in 15–25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom [2015]

United States

• Academic Pediatrics
  • Recommending Human Papillomavirus Vaccination at Age 9: A National Survey of Primary Care Professionals [2022]

• American Academy of Pediatrics
  • Why AAP recommends initiating HPV vaccination as early as age 9 [2019]

• American Cancer Society
  • Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation [2020]
  • Guidelines for Human Papillomavirus Vaccine Use

• American College of Obstetricians and Gynecologists
  • Adjuvant Human Papillomavirus Vaccination for Patients Undergoing Treatment for Cervical Intraepithelial Neoplasia 2+ [2023]
  • Human Papillomavirus Vaccination [2020]

• American Society of Clinical Oncology
  • Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline [2017]
  • American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention [2016]
  • Primary Prevention of Cervical Cancer Resource-Stratified Guideline

• BMC Pediatrics
  • Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008–2012 [2017]

• CA: A Cancer Journal for Clinicians
  • Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review [2022]

• Cancer Causes and Control
  • Lower human papillomavirus vaccine initiation and completion among Asian American adolescents compared to their peers: National Health and Nutritional Examination Survey 2011-2018 [2023]

• Cancer Epidemiology Biomarkers & Prevention
  • Disparities in healthcare providers’ recommendation of HPV vaccination for US adolescents: A systematic review [2021]
  • Assessing Impact of HPV Vaccination on Cervical Cancer Incidence in Women 15–29 years in the United States, 1999–2017: An Ecologic Study [2021]

• Centers for Disease Control and Prevention
  • Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018 [2021]
  • Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices [2019]
  • Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices [2016]
  • Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices [2015]
  • Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans — United States, 2013 [2015]
  • National Human Papillomavirus Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey – Teen, United States, 2011 [2014]
  • Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP) [2014]
  • Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States [2014]
  • CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease [2014]
  • Surveillance Manual | HPV
  • Safety Information for HPV Vaccine
  • HPV Vaccine Schedule and Dosing
  • HPV Vaccination | For Providers

• Food and Drug Administration
  • Gardasil

• Frontiers in Oncology
  • Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination [2016]

• Human Vaccines & Immunotherapeutics
  • Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities [2023]
  • Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020 [2023]
  • How to make effective HPV vaccine recommendations starting at age 9 [2023]
  • HPV vaccine recommendations by age: A survey of providers in federally qualified health centers [2023]
  • Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10 [2023]
  • Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen [2023]
  • Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9 [2022]
  • The influence of parent-child gender on intentions to refuse HPV vaccination due to safety concerns/side effects, National Immunization Survey - Teen, 2010-2019 [2022]
  • Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13–17 by metropolitan statistical area (MSA) status, National Immunization Survey – Teen, 2013 – 2017 [2020]
  • Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature [2019]
  • Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule [2015]

• International Journal of Cancer
  • Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening [2020]

• JAMA Health Forum
  • Prevalence of Human Papillomavirus Infection Among Women Born in the 1990s vs the 1980s and Association With HPV Vaccination in the US [2022]
  • Human Papillomavirus Vaccine Administration Trends Among Commercially Insured US Adults Aged 27-45 Years Before and After Advisory Committee on Immunization Practices Recommendation Change, 2007-2020 [2022]

• JAMA Network Open
  • Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017 [2022]
  • Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women [2019]

• JAMA Pediatrics
  • Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US [2022]

• Journal of Adolescent Health
  • Getting Human Papillomavirus Vaccination Back on Track: A National Survey [2023]
  • Levels of Parental Human Papillomavirus Vaccine Hesitancy and Their Reasons for Not Intending to Vaccinate: Insights From the 2019 National Immunization Survey-Teen [2022]

• Journal of Immigrant and Minority Health
  • Nativity Differences in Awareness and Knowledge About HPV Infection and Vaccination Among U.S. Adults: Findings from a National Population-Based Sample [2022]

• National Cancer Institute
  • Human Papillomavirus (HPV) Vaccines

• Obstetrics & Gynecology Clinics of North America
  • Human Papillomavirus Vaccination: Current Indications and Future Directions [2013]

• Preventive Medicine Reports
  • Obstetrician/gynecologists’ HPV vaccination recommendations among women and girls 26 and younger [2022]
  • Association between patient characteristics and HPV vaccination recommendation for postpartum patients: A national survey of Obstetrician/Gynecologists [2022]

• Society for Adolescent Health and Medicine
  • Human Papillomavirus (HPV) Vaccine: A Position Statement of the Society for Adolescent Medicine [2006]

• Vaccine
  • Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis [2021]
  • Regional variations in human papillomavirus prevalence across time in NHANES (2003–2014) [2019]
  • Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers [2014]

• Vaccines
  • Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019–2020 [2022]

WHO

• International Agency for Research on Cancer
  • Protection from a Single Dose of HPV Vaccine [2023]

• World Health Organization
  • Considerations for human papillomavirus (HPV) vaccine product choice [2024]
  • User manual for WHO cervical cancer prevention and control costing tool: HPV vaccination module (C4P-HPV tool) [2023]
  • Human papillomavirus vaccines: WHO position paper, May 2022 [2022]
  • Global market study: HPV vaccines [2022]
  • Human papillomavirus (HPV) vaccine coverage monitoring manual [2020]
  • HPV Vaccine Coverage Monitoring Manual [2020]
  • Scaling-up HPV vaccine introduction [2016]
  • HPV vaccine communication: special considerations for a unique vaccine. 2016 update [2016]
  • Guide to introducing HPV vaccine into national immunization programmes [2016]
  • The immunological basis for immunization series: module 19: human papillomavirus infection [2011]
  • Report of the meeting on HPV vaccine coverage and impact monitoring, 16-17 November 2009, Geneva, Switzerland [2010]
  • Cervical cancer, human papillomavirus (HPV) and HPV vaccines : key points for policy-makers and health professionals [2007]
  • Immunizing against HPV
  • Girls aged 15 years old that received the recommended doses of HPV vaccine

WHO Western Pacific Region

• Vaccines
  • A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region [2021]

Zimbabwe

• Infectious Agents and Cancer
  • Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe [2014]

• Vaccine
  • HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls [2022]

{Related topics}

• Topic
  • Genital warts, HPV vaccine for men
  • Cervical cancer: screening, prevention
  • Cervical cancer